Vianello et al. [160] found higher expression of the mitophagic factor BNIP3 levels and enhanced mitophagy in both in vitro cisplatin (CDDP) resistant models and cancer patients’ samples resistant to platinum-based chemotherapy. This evidence concerns the gene BNIP3 and cancer.